Absolute risk low, but findings may help inform treatment decisions, say researchers Use of glucagon-like peptide-1 (GLP-1) receptor agonists used to treat type 2 diabetes and obesity are associated with an increased…

1 points•Bluestein•about 7 hours ago•0 comments•

0 comments

No comments yet.

Related stories